Between 2000 and 2020, Medtronic filed 16845 patent applications at the USPTO and abandoned 2290 (13.59%) patent applications.
A patent-led view of where GLP-2 innovation is moving – from peptide and biologic protection toward longer-acting therapies, formulations, dosing, manufacturing, oral delivery, and multi-receptor strategies. GLP-2 Is Entering a…
Viatris has a total of 3371 patents globally, out of which 1550 have been granted. Of these 3371 patents, 22.15% patents are active. India is where Viatris has filed the…
Innoviva has a total of 1936 patents globally, out of which 1012 have been granted. Of these 1936 patents, more than 30% patents are active. Europe (EPO) is where Innoviva…
